Diffuse Large B-Cell Lymphoma: A Rare Cause of Lung Consolidation

  • Aditya Jandial
  • Kundan Mishra
  • Pranab Dey
  • Deepak Goni
  • Mohd Umair
  • Deepesh Lad
  • Gaurav Prakash
  • Alka Khadwal
  • Neelam Varma
  • Pankaj MalhotraEmail author


Diffuse large B-cell lymphoma (DLBCL) is the commonest sub-type of non-Hodgkin lymphoma. However, lung consolidation is a rare presentation of DLBCL. Moreover, in view of poor general condition, it poses clinical dilemma of when to start chemotherapy and whether chemotherapy should be given at full dose or truncated doses till improvement in general condition. A 48-years-old lady was admitted with complaints of non-productive cough for 2 months duration. She was febrile and hypoxemic requiring oxygen supplementation. She had bilateral axillary lymphadenopathy, and bronchial breath sounds on chest auscultation. Chest X-ray showed non-homogenous opacities involving bilateral lower zones. A diagnosis of DLBCL was confirmed on lymph node biopsy and Immunohistochemistry. She received chemotherapy, following which a gradual, improvement in her breathlessness and cough was noted over ensuing week and she got discharged from the hospital and received rest of her chemotherapy on outpatient basis. In a case of DLBCL with lung consolidation, a high index of suspicion can clinch the diagnosis of secondary lymphomatous involvement. Presence of respiratory failure at presentation doesn’t necessarily warrants truncation of chemotherapy doses.


Lymphoma Pneumonia Infection Emergency medicine Chemotherpy Imaging 


Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Informed Consent

Informed signed written consent was taken from the patient involved.

Ethical Approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Human and Animals Rights

No animals were involved in the study.


  1. 1.
    Campo E, Swerdlow SH, Harris NL, Pileri S, Stein H, Jaffe ES (2011) The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications. Blood 117(19):5019–5032CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Sehn LH, Gascoyne RD (2015) Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity. Blood 125(1):22–32CrossRefPubMedGoogle Scholar
  3. 3.
    Gurney KA, Cartwright RA (2002) Increasing incidence and descriptive epidemiology of extranodal non-Hodgkin lymphoma in parts of England and Wales. Hematol J 3:95–104CrossRefPubMedGoogle Scholar
  4. 4.
    Malhotra P (2011) Hematopoietic and lymphoid neoplasm of lungs. In: Jindal SK (ed) Text book of pulmonary medicine: a developing countries perspective, 1st edn. Jaypee Brothers Medical Publishers (P) Ltd, New DelhiGoogle Scholar
  5. 5.
    Mian M, Wasle I, Gritsch S et al (2015) B cell lymphoma with lung involvement: what is it about? Acta Haematol 133(2):221–225CrossRefPubMedGoogle Scholar
  6. 6.
    Lee J, Park H, Kim YW, Yoo CG (2016) Pulmonary lymphoma misdiagnosed as pneumonia. Indian J Hematol Blood Transfus 32(4):509–511CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Sahu KK, Badhala P, Malhotra P, Aggarwal AN (2016) A rare case of rituximab induced interstitial lung disease. Lung India 33(4):472–473CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Indian Society of Hematology and Blood Transfusion 2018

Authors and Affiliations

  1. 1.Department of Internal MedicinePostgraduate Institute of Medical Education and ResearchChandigarhIndia
  2. 2.Department of HistopathologyPostgraduate Institute of Medical Education and ResearchChandigarhIndia
  3. 3.Department of HematologyPostgraduate Institute of Medical Education and ResearchChandigarhIndia

Personalised recommendations